000			02017 a2200553 4500
005			20250517152318.0
264		0	_c20180521
008			201805s 0 0 eng d
022			_a1938-0682
024	7		_a10.1016/j.clgc.2017.03.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aBouman-Wammes, Esther W
245	0	0	_aBenefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. _h[electronic resource]
260			_bClinical genitourinary cancer _c10 2017
300			_ae773-e782 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAndrogen Antagonists _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aCholine _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aHumans
650	0	4	_aLymphatic Metastasis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms, Second Primary _xdiagnostic imaging
650	0	4	_aPositron Emission Tomography Computed Tomography _xmethods
650	0	4	_aProstatic Neoplasms _xdiagnostic imaging
650	0	4	_aRadiosurgery
650	0	4	_aRetrospective Studies
650	0	4	_aTime-to-Treatment
650	0	4	_aTreatment Outcome
700	1		_avan Dodewaard-De Jong, Joyce M
700	1		_aDahele, Max
700	1		_aCysouw, Matthijs C F
700	1		_aHoekstra, Otto S
700	1		_avan Moorselaar, R Jeroen A
700	1		_aPiet, Maartje A H
700	1		_aVerberne, Hein J
700	1		_aBins, Adriaan D
700	1		_aVerheul, Henk M W
700	1		_aSlotman, Ben J
700	1		_aOprea-Lager, Daniela E
700	1		_aVan den Eertwegh, Alfons J M
773	0		_tClinical genitourinary cancer _gvol. 15 _gno. 5 _gp. e773-e782
856	4	0	_uhttps://doi.org/10.1016/j.clgc.2017.03.009 _zAvailable from publisher's website
999			_c27132892 _d27132892